R, M., MB, P., S, M., D, G., & LS, L. (2017). Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting. Dove Medical Press.
Style de citation Chicago (17e éd.)R, Mudad, Patel MB, Margunato-Debay S, Garofalo D, et Lal LS. Comparative Effectiveness and Safety of Nab-paclitaxel Plus Carboplatin Vs Gemcitabine Plus Carboplatin in First-line Treatment of Advanced Squamous Cell Non-small Cell Lung Cancer in a US Community Oncology Setting. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)R, Mudad, et al. Comparative Effectiveness and Safety of Nab-paclitaxel Plus Carboplatin Vs Gemcitabine Plus Carboplatin in First-line Treatment of Advanced Squamous Cell Non-small Cell Lung Cancer in a US Community Oncology Setting. Dove Medical Press, 2017.